JERSEY, Channel Islands,12 April 2021 (GLOBE NEWSWIRE) --Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the company has been recognized with a 2021 Red Dot Product Design Award for the full MosaiQ™ by Quotient system. 

JERSEY, Channel Islands, 12 January 2021(GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced it has been named a winner in the prestigious 2021 BIG Innovation Awards presented by the Business Intelligence Group.

Take an insider look at how our MosaiQ instrument is used at Bloodworks Northwest, and hear what a Bloodworks technologist and a donor have to say about our technology: 

JERSEY, Channel Islands, 28 September 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), headquartered in Eysins, Switzerland, today announced that on September 25, 2020, the U.S.

JERSEY, Channel Islands, August 4, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today published the latest investor presentation associated with the earnings call for fiscal quarter ended June 30, 2020.

•    Significant progress in three targeted areas of MosaiQ development – COVID-19 antibody test, potential new applications, and transfusion diagnostics 
•    Ten commercial placements of MosaiQ platform in Europe and the US

JERSEY, Channel Islands, 23 July 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland today announced that Dr. Isabelle Buckle, Ph.D. and Dr. Catherine Larue, Ph.D.

JERSEY, Channel Islands, 23 July 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland today announced changes in the composition of its board of directors that will take effect later this year.